Home Industry Biotech company Brinter joins Winston Starts Accelerator

Biotech company Brinter joins Winston Starts Accelerator

Finnish-American biotech company Brinter has been accepted into the Winston Starts Accelerator. This collaboration opens up growth opportunities for Brinter in the southeastern United States. Winston Starts, known for its commitment to fostering startup success, has become an invaluable resource for local entrepreneurs looking to grow their companies.

“We are extremely excited to join the Winston Starts. This partnership will accelerate our growth trajectory and provide us access to top-tier mentors and investors who can guide us through the intricacies of scaling our business”, says Tom Alapaattikoski, CEO of Brinter.

Stan Parker, president of Winston Starts, has played a critical role in Brinter’s development in North Carolina to date, connecting the company with key partners and industry experts. Brinter acknowledges Parker’s invaluable support and thanks him for the doors he has opened.

“Stan Parker have been instrumental in helping us navigate the startup landscape in North Carolina. Winston Starts support and guidance have already proven invaluable, and we are eager to tap into their expertise to further drive our science and success”, states Dr. Matthew Brovold, Science Manager of Brinter.

Brinter is revolutionizing the implant industry with its personalized 3D printed bio-implants. Participation in the Winston Starts Accelerator and Mentorship Program creates new opportunities for collaboration and growth. This inclusion highlights Brinter’s potential and underscores the company’s commitment to realizing its vision of personalized bio-implants.


Subscribe to our Newsletter

3DPResso is a weekly newsletter that links to the most exciting global stories from the 3D printing and additive manufacturing industry.

Privacy Policy*
 

You can find the privacy policy for the newsletter here. You can unsubscribe from the newsletter at any time. For further questions, you can contact us here.